Surveillance and screening for hepatocellular carcinoma

Jorge A. Marrero, Hero K. Hussain

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The decision to screen an at-risk population for cancer is based on well-established criteria. Although the overall goal is to reduce morbidity and mortality from cancer, the objective of screening is to use a relatively simple and inexpensive test in a large number of individuals to determine whether they are likely or unlikely to have the cancer for which they are being screened. Screening is the one-time application of a test that allows detection of preclinical tumors, tumors at an early stage when they are asymptomatic with no clinical suspicion, and when curative intervention may achieve the goal of reducing morbidity and mortality. Surveillance is the continuous monitoring of disease occurrence (using the screening test) within a population to accomplish the same goals of screening. Criteria have been developed, first promoted by the World Health Organization, to assess the benefits of screening for a specific disease. This review will evaluate the process of screening/surveillance for hepatocellular carcinoma (HCC). Cirrhosis has been recognized as the most important risk factor for the development of HCC. Hepatitis C (HCV) and hepatitis B (HBV) are the major etiological agents that lead to the development of HCC. HCV-associated cirrhosis is the causative agent that has been largely responsible for the increase in incidence of HCC in the United States. However, HBV is the leading cause of HCC worldwide, particularly in Asia and Africa. Therefore, there is a target population to which surveillance tests can be applied.

Original languageEnglish (US)
Title of host publicationPrimary Carcinomas of the Liver
PublisherCambridge University Press
Pages10-15
Number of pages6
Volume9780521519519
ISBN (Print)9780511770807, 9780521519519
DOIs
StatePublished - Jan 1 2009

Fingerprint

Hepatocellular Carcinoma
Neoplasms
Fibrosis
Morbidity
Mortality
Health Services Needs and Demand
Hepatitis C
Hepatitis B
Early Detection of Cancer
Incidence
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Marrero, J. A., & Hussain, H. K. (2009). Surveillance and screening for hepatocellular carcinoma. In Primary Carcinomas of the Liver (Vol. 9780521519519, pp. 10-15). Cambridge University Press. https://doi.org/10.1017/CBO9780511770807.004

Surveillance and screening for hepatocellular carcinoma. / Marrero, Jorge A.; Hussain, Hero K.

Primary Carcinomas of the Liver. Vol. 9780521519519 Cambridge University Press, 2009. p. 10-15.

Research output: Chapter in Book/Report/Conference proceedingChapter

Marrero, JA & Hussain, HK 2009, Surveillance and screening for hepatocellular carcinoma. in Primary Carcinomas of the Liver. vol. 9780521519519, Cambridge University Press, pp. 10-15. https://doi.org/10.1017/CBO9780511770807.004
Marrero JA, Hussain HK. Surveillance and screening for hepatocellular carcinoma. In Primary Carcinomas of the Liver. Vol. 9780521519519. Cambridge University Press. 2009. p. 10-15 https://doi.org/10.1017/CBO9780511770807.004
Marrero, Jorge A. ; Hussain, Hero K. / Surveillance and screening for hepatocellular carcinoma. Primary Carcinomas of the Liver. Vol. 9780521519519 Cambridge University Press, 2009. pp. 10-15
@inbook{64d43802344043ebb54354ab0130d2eb,
title = "Surveillance and screening for hepatocellular carcinoma",
abstract = "The decision to screen an at-risk population for cancer is based on well-established criteria. Although the overall goal is to reduce morbidity and mortality from cancer, the objective of screening is to use a relatively simple and inexpensive test in a large number of individuals to determine whether they are likely or unlikely to have the cancer for which they are being screened. Screening is the one-time application of a test that allows detection of preclinical tumors, tumors at an early stage when they are asymptomatic with no clinical suspicion, and when curative intervention may achieve the goal of reducing morbidity and mortality. Surveillance is the continuous monitoring of disease occurrence (using the screening test) within a population to accomplish the same goals of screening. Criteria have been developed, first promoted by the World Health Organization, to assess the benefits of screening for a specific disease. This review will evaluate the process of screening/surveillance for hepatocellular carcinoma (HCC). Cirrhosis has been recognized as the most important risk factor for the development of HCC. Hepatitis C (HCV) and hepatitis B (HBV) are the major etiological agents that lead to the development of HCC. HCV-associated cirrhosis is the causative agent that has been largely responsible for the increase in incidence of HCC in the United States. However, HBV is the leading cause of HCC worldwide, particularly in Asia and Africa. Therefore, there is a target population to which surveillance tests can be applied.",
author = "Marrero, {Jorge A.} and Hussain, {Hero K.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1017/CBO9780511770807.004",
language = "English (US)",
isbn = "9780511770807",
volume = "9780521519519",
pages = "10--15",
booktitle = "Primary Carcinomas of the Liver",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Surveillance and screening for hepatocellular carcinoma

AU - Marrero, Jorge A.

AU - Hussain, Hero K.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - The decision to screen an at-risk population for cancer is based on well-established criteria. Although the overall goal is to reduce morbidity and mortality from cancer, the objective of screening is to use a relatively simple and inexpensive test in a large number of individuals to determine whether they are likely or unlikely to have the cancer for which they are being screened. Screening is the one-time application of a test that allows detection of preclinical tumors, tumors at an early stage when they are asymptomatic with no clinical suspicion, and when curative intervention may achieve the goal of reducing morbidity and mortality. Surveillance is the continuous monitoring of disease occurrence (using the screening test) within a population to accomplish the same goals of screening. Criteria have been developed, first promoted by the World Health Organization, to assess the benefits of screening for a specific disease. This review will evaluate the process of screening/surveillance for hepatocellular carcinoma (HCC). Cirrhosis has been recognized as the most important risk factor for the development of HCC. Hepatitis C (HCV) and hepatitis B (HBV) are the major etiological agents that lead to the development of HCC. HCV-associated cirrhosis is the causative agent that has been largely responsible for the increase in incidence of HCC in the United States. However, HBV is the leading cause of HCC worldwide, particularly in Asia and Africa. Therefore, there is a target population to which surveillance tests can be applied.

AB - The decision to screen an at-risk population for cancer is based on well-established criteria. Although the overall goal is to reduce morbidity and mortality from cancer, the objective of screening is to use a relatively simple and inexpensive test in a large number of individuals to determine whether they are likely or unlikely to have the cancer for which they are being screened. Screening is the one-time application of a test that allows detection of preclinical tumors, tumors at an early stage when they are asymptomatic with no clinical suspicion, and when curative intervention may achieve the goal of reducing morbidity and mortality. Surveillance is the continuous monitoring of disease occurrence (using the screening test) within a population to accomplish the same goals of screening. Criteria have been developed, first promoted by the World Health Organization, to assess the benefits of screening for a specific disease. This review will evaluate the process of screening/surveillance for hepatocellular carcinoma (HCC). Cirrhosis has been recognized as the most important risk factor for the development of HCC. Hepatitis C (HCV) and hepatitis B (HBV) are the major etiological agents that lead to the development of HCC. HCV-associated cirrhosis is the causative agent that has been largely responsible for the increase in incidence of HCC in the United States. However, HBV is the leading cause of HCC worldwide, particularly in Asia and Africa. Therefore, there is a target population to which surveillance tests can be applied.

UR - http://www.scopus.com/inward/record.url?scp=84927092439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927092439&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511770807.004

DO - 10.1017/CBO9780511770807.004

M3 - Chapter

AN - SCOPUS:84927092439

SN - 9780511770807

SN - 9780521519519

VL - 9780521519519

SP - 10

EP - 15

BT - Primary Carcinomas of the Liver

PB - Cambridge University Press

ER -